In March 2025, the company declared new designs for the direct-to-shopper offering of its Wegovy weight loss drug. The company established a different pharmacy, known as NovoCare, which would cost customers $499 monthly for usage of the drug, lower than half the price of the drug as a result of other pharmaceutical distribution networks.[fifty thre